Robert F. Doman

Robert F. Doman has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Dusa Pharmaceuticals Inc and Echo Therapeutics, Inc. Between 17 March 2006 and 1 October 2013, the trades on record add up to 31 filings.

On the market, this insider has only ever bought: 5 purchases, €40k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 17 share grants. In 2013 alone, the filings show 1 purchase and no sales.

The median purchase comes to €7,181.

The newest entry dates from 2 October 2013: a share grant, in Echo Therapeutics, Inc. The clock since the last published purchase (25 March 2013) now reads 4,961 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.